On May 16, 2024, GSK plc reported several transactions involving the purchase and sale of Ordinary Shares by key personnel, including Sally Jackson, who sold 1,120 shares at £17.88, and Dr. Hal Barron, who acquired 2,432.67 ADSs at $44.88 as dividend reinvestments.